|
|
||||||||


,
,
* Center for Neurovirology and Neurodegenerative Disorders, the Departments of
Pathology and Microbiology,
Medicine,
The Eppley Institute for Cancer and Allied Diseases, and
|| College of Pharmacy, University of Nebraska Medical Center, Omaha
Correspondence: Yuri Persidsky, M.D., Ph.D., Center for Neurovirology and Neurodegenerative Disorders, 985215 Nebraska Medical Center, Omaha, NE 68198-5215. E-mail: ypersids{at}unmc.edu
The neuropathogenesis of HIV-1 infection revolves around the production
of secretory factors from immune-activated brain mononuclear phagocytes
(MP). MP-secreted chemokines may play several roles in HIV-1
encephalitis (HIVE). These can promote macrophage brain infiltration,
blood-brain barrier (BBB) and neuronal dysfunction during
HIV-1-associated dementia. We investigate how HIV-1-infected MP
regulates the production of chemokines and how they influence HIV-1
neuropathogenesis. We demonstrate that HIV-1-infected and
immune-activated MP (for example, microglia) and astrocytes produce
ß-chemokines in abundance, as shown in both laboratory assays and
within infected brain tissue. HIV-1-infected microglia significantly
modulate monocyte migration in a BBB model system and in brains of SCID
mice with HIVE. HIV-1-infected MP down-regulate tight junction protein
and special polarized transport systems on brain microvascular
endothelial cells as shown in human autopsy brain tissue and in SCID
mice with HIVE. Chemokines can damage neurons directly. Toxicity caused
by binding of stromal-derived factor-1
to its receptor on neurons
exemplifies such mechanism. In toto, these works
underscore the diverse roles of chemokines in HIV-1 neuropathogenesis
and lay the foundation for future therapeutic
interventions.
Key Words: chemokine chemokine receptor endothelial cell microglia astrocyte tight junction
This article has been cited by other articles:
![]() |
H. Wang, J. Sun, and H. Goldstein Human Immunodeficiency Virus Type 1 Infection Increases the In Vivo Capacity of Peripheral Monocytes To Cross the Blood-Brain Barrier into the Brain and the In Vivo Sensitivity of the Blood-Brain Barrier to Disruption by Lipopolysaccharide J. Virol., August 1, 2008; 82(15): 7591 - 7600. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sun, J. H. Zheng, M. Zhao, S. Lee, and H. Goldstein Increased In Vivo Activation of Microglia and Astrocytes in the Brains of Mice Transgenic for an Infectious R5 Human Immunodeficiency Virus Type 1 Provirus and for CD4-Specific Expression of Human Cyclin T1 in Response to Stimulation by Lipopolysaccharides J. Virol., June 1, 2008; 82(11): 5562 - 5572. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Chaudhuri, B. Yang, H. E. Gendelman, Y. Persidsky, and G. D. Kanmogne STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier Blood, February 15, 2008; 111(4): 2062 - 2072. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Tsai, L.-Y. Chung, E.-R. Chen, Y.-C. Liu, S. S.-J. Lee, Y.-S. Chen, C.-L. Sy, S.-R. Wann, and C.-M. Yen Association of Matrix Metalloproteinase-9 and Tissue Inhibitors of Metalloproteinase-4 in Cerebrospinal Fluid with Blood-Brain Barrier Dysfunction in Patients with Eosinophilic Meningitis Caused by Angiostrongylus cantonensis Am J Trop Med Hyg, January 1, 2008; 78(1): 20 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Clay, D. S. Rodrigues, Y. S. Ho, B. A. Fallert, K. Janatpour, T. A. Reinhart, and U. Esser Neuroinvasion of Fluorescein-Positive Monocytes in Acute Simian Immunodeficiency Virus Infection J. Virol., November 1, 2007; 81(21): 12040 - 12048. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Persidsky, D. Heilman, J. Haorah, M. Zelivyanskaya, R. Persidsky, G. A. Weber, H. Shimokawa, K. Kaibuchi, and T. Ikezu Rho-mediated regulation of tight junctions during monocyte migration across the blood-brain barrier in HIV-1 encephalitis (HIVE) Blood, June 15, 2006; 107(12): 4770 - 4780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-O. Kim, H.-S. Suh, Q. Si, B. I. Terman, and S. C. Lee Anti-CD45RO Suppresses Human Immunodeficiency Virus Type 1 Replication in Microglia: Role of Hck Tyrosine Kinase and Implications for AIDS Dementia J. Virol., January 1, 2006; 80(1): 62 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Harrington, D. W. Haas, K. Ritola, and R. Swanstrom Compartmentalized Human Immunodeficiency Virus Type 1 Present in Cerebrospinal Fluid Is Produced by Short-Lived Cells J. Virol., July 1, 2005; 79(13): 7959 - 7966. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. McArthur, M. P. McDermott, D. McClernon, C. St Hillaire, K. Conant, K. Marder, G. Schifitto, O. A. Selnes, N. Sacktor, Y. Stern, et al. Attenuated Central Nervous System Infection in Advanced HIV/AIDS With Combination Antiretroviral Therapy Arch Neurol, November 1, 2004; 61(11): 1687 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Archibald, E. Masliah, C. Fennema-Notestine, T. D. Marcotte, R. J. Ellis, J. A. McCutchan, R. K. Heaton, I. Grant, M. Mallory, A. Miller, et al. Correlation of In Vivo Neuroimaging Abnormalities With Postmortem Human Immunodeficiency Virus Encephalitis and Dendritic Loss Arch Neurol, March 1, 2004; 61(3): 369 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Persidsky and H. E. Gendelman Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection J. Leukoc. Biol., November 1, 2003; 74(5): 691 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, G. Davis-Gorman, R. R. Watson, and P. F. McDonagh ETHANOL MODULATES CORONARY PERMEABILITY TO MACROMOLECULES IN MURINE AIDS Alcohol Alcohol., November 1, 2002; 37(6): 555 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Montaner, C.-F. Perno, and S. Crowe Macrophage infection by HIV-1: focus on viral reservoirs and pathogenesis J. Leukoc. Biol., September 1, 2000; 68(3): 301 - 302. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |